These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 19100416)
1. Therapeutic effect of Tripterygium wilfordii on proteinuria associated with sirolimus in renal transplant recipients. Ji SM; Li LS; Wen JQ; Sha GZ; Cheng Z; Cheng DR; Chen JS; Liu ZH Transplant Proc; 2008 Dec; 40(10):3474-8. PubMed ID: 19100416 [TBL] [Abstract][Full Text] [Related]
2. Clinical trial of Tripterygium Wilfordii Hook F. in human kidney transplantation in China. Ji SM; Wang QW; Chen JS; Sha GZ; Liu ZH; Li LS Transplant Proc; 2006 Jun; 38(5):1274-9. PubMed ID: 16797280 [TBL] [Abstract][Full Text] [Related]
3. Proteinuria after conversion to sirolimus in renal transplant recipients. Sahin GM; Sahin S; Kantarci G; Ergin H Transplant Proc; 2006 Dec; 38(10):3473-5. PubMed ID: 17175308 [TBL] [Abstract][Full Text] [Related]
4. Proteinuria in transplant patients associated with sirolimus. Franco AF; Martini D; Abensur H; Noronha IL Transplant Proc; 2007 Mar; 39(2):449-52. PubMed ID: 17362756 [TBL] [Abstract][Full Text] [Related]
5. Influence of sirolimus on proteinuria in de novo kidney transplantation with expanded criteria donors: comparison of two CNI-free protocols. Diekmann F; Gutiérrez-Dalmau A; López S; Cofán F; Esforzado N; Ricart MJ; Rossich E; Saval N; Torregrosa JV; Oppenheimer F; Campistol JM Nephrol Dial Transplant; 2007 Aug; 22(8):2316-21. PubMed ID: 17452413 [TBL] [Abstract][Full Text] [Related]
6. Treatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trial. Ge Y; Xie H; Li S; Jin B; Hou J; Zhang H; Shi M; Liu Z J Transl Med; 2013 May; 11():134. PubMed ID: 23725518 [TBL] [Abstract][Full Text] [Related]
7. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes. Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960 [TBL] [Abstract][Full Text] [Related]
8. Factors associated with proteinuria in renal transplant recipients treated with sirolimus. Liew A; Chiang GS; Vathsala A Transpl Int; 2009 Mar; 22(3):313-22. PubMed ID: 19054382 [TBL] [Abstract][Full Text] [Related]
9. Conversion from a calcineurin inhibitor-based immunosuppressive regimen to everolimus in renal transplant recipients: effect on renal function and proteinuria. Morales J; Fierro A; Benavente D; Zehnder C; Ferrario M; Contreras L; Herzog C; Buckel E Transplant Proc; 2007 Apr; 39(3):591-3. PubMed ID: 17445551 [TBL] [Abstract][Full Text] [Related]
10. Evolution of glomerular filtration rate, renal injury markers, anemia, and angiotensin blockers use after change from calcineurin inhibitors to sirolimus in transplant patients with neoplasia versus chronic allograft nephropathy. Luna E; Cerezo I; Macias R; Villa J; Martinez C; Cubero J; Martinez R; Ferreira F; García C Transplant Proc; 2011; 43(6):2187-90. PubMed ID: 21839229 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the efficacy and safety of TWHF in diabetic nephropathy patients with overt proteinuria and normal eGFR. Xiong C; Li L; Bo W; Chen H; XiaoWei L; Hongbao L; Peng Z J Formos Med Assoc; 2020 Mar; 119(3):685-692. PubMed ID: 31801679 [TBL] [Abstract][Full Text] [Related]
13. Is sirolimus responsible for proteinuria? Dervaux T; Caillard S; Meyer C; Ellero B; Woehl-Jaegle ML; Hannedouche T; Wolf P; Moulin B Transplant Proc; 2005; 37(6):2828-9. PubMed ID: 16182822 [TBL] [Abstract][Full Text] [Related]
14. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial. Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF; Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398 [TBL] [Abstract][Full Text] [Related]
15. [Therapeutic effect of Tripterygium wilfordii multiglycosides on proteinuria in kidney transplant recipients]. Huang Y; Long TB; Zhan F; Pan CY; Chen DJ; Lin SD Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2269-71. PubMed ID: 19114376 [TBL] [Abstract][Full Text] [Related]
16. Subclinical Lesions and Donor-Specific Antibodies in Kidney Transplant Recipients Receiving Tacrolimus-Based Immunosuppressive Regimen Followed by Early Conversion to Sirolimus. de Sandes-Freitas TV; Felipe CR; Campos ÉF; de Lima MG; Soares MF; de Franco MF; Aguiar WF; Tedesco-Silva H; Medina-Pestana JO Transplantation; 2015 Nov; 99(11):2372-81. PubMed ID: 25929604 [TBL] [Abstract][Full Text] [Related]